ScienceDex / Researcher record
Steven P. Balk
- Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)
- Dana-Farber Cancer Institute (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,125,505 | 5 | #4,812 |
| 2025 | $2,842,375 | 6 | #3,737 |
| 2026 | $18,920,744 | 5 | #203 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected5 records
- FY20256 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Citation measures
From OpenAlex data as of September 23, 2026. Google Scholar and Scopus count other sources, so their numbers differ.
Each number opens a page that explains the measure and compares researchers on it.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1863884Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-4546-7371Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing Steven P. Balk as a PI. Multi-PI records show the full award amount for context.
- 5R01CA266704-03R01Contact PIEnhancing the Efficacy of Docetaxel in Prostate CancerBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$621.8Kaward amount
- $509.8Kaward amount
- 5R01CA262536-04R01Contact PIProstate Cancer Vulnerabilities to BH3 Mimetic DrugsBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$380.3Kaward amount
- 5R01CA272934-02R01Contact PIWNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate CancerBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$375.7Kaward amount
- $237.8Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Steven P. Balk as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBeth Israel Deaconess Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4812
- 2024Entered Top 25% NationallyRanked #4812
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026$10M Cumulative Funding
- 2026Entered Top 10% NationallyRanked #203
- 2026Entered Top 5% NationallyRanked #203
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Steven P. Balk.